Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Content Type
      Content Type
      Clear All
      Content Type
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Item Type
    • Is Full-Text Available
    • Subject
    • Country Of Publication
    • Publisher
    • Source
    • Target Audience
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
6 result(s) for "Etching, Spanish"
Sort by:
Moors and the Bullfight: History and National Identity in Goya's Tauromaquia
Francisco Goya's representation of the history of the bullfight in the Tauromaquia series (1815-16) provides important insights into national identity formation in early-nineteenth-century Spain. These prints give the Muslims of al-Andalus an unprecedented (and historically unfounded) role in the evolution of this quintessentially Spanish pastime. By equating national belonging with the development of cultural practices that transcend religious difference, the Tauromaquia absorbs the Islamic past into the fabric of Spanish history. In doing so it marks a significant departure from the ideology of Christian Reconquest, which took on renewed significance following the Peninsular War with Napoleonic France (1808-13).
RealPennies: Alerts: Turning Pennies into Dollars (OTC: HLUN), (NASDAQ: AMGN), (NYSE: DNA), (NASDAQ: CELG)
M2 PRESSWIRE-March 23, 2007-RealPennies: Alerts: Turning Pennies into Dollars (OTC: HLUN), (NASDAQ: AMGN), (NYSE: DNA), (NASDAQ: CELG) (C)1994-2007 M2 COMMUNICATIONS LTD RealPennies.com ALERTS: reporting on dollar volume movers: Healtheuniverse, Inc. (OTC: HLUN), Amgen Inc. (NASDAQ: AMGN), Genentech Inc. (NYSE: DNA), Celgene Corp. (NASDAQ: CELG) Amgen Inc. (NASDAQ: AMGN) on Thursday said that it pulled its Vectibix treatment from clinical trials after tests showed that combination use of the drug with Avastin in patients with metastatic colon cancer worsened the progression of the disease. Amgen canceled the trial after the first 231 incidences of disease progression or patient death. Amgen was testing the addition of Vectibix in combination with chemotherapy and Genentech Inc.'s Avastin. The drug is already approved solely to treat colon cancer in combination with chemotherapy.